Briefing
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.
GALAXY, an observational arm of CIRCULATE-Japan, measured ctDNA before and after surgery in 1,039 people with stage II-IV resectable colorectal cancer and related it to adjuvant chemotherapy. The abstract excerpt does not name the assay.
- Design: Evidence level 2
- Assay: Not named in the abstract
Nature MedicinePubMed 36646802DOI 10.1038/s41591-022-02115-4